Tasly Pharmaceutical Group Co., Ltd (600535.SS)
CNY 15.05
(-1.05%)
CNY 15.05
(-1.05%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.41 Billion CNY | -2.64% |
| 2022 | 1.45 Billion CNY | 30.04% |
| 2021 | 1.11 Billion CNY | 9.41% |
| 2020 | 1.02 Billion CNY | -68.44% |
| 2019 | 3.23 Billion CNY | -37.31% |
| 2018 | 5.15 Billion CNY | 478.33% |
| 2017 | 891.5 Million CNY | 123.15% |
| 2016 | 399.5 Million CNY | -49.96% |
| 2015 | 798.44 Million CNY | -1.7% |
| 2014 | 812.22 Million CNY | -6.49% |
| 2013 | 868.62 Million CNY | 73.48% |
| 2012 | 500.7 Million CNY | 694.65% |
| 2011 | 63 Million CNY | -72.0% |
| 2010 | 225 Million CNY | 0.0% |
| 2009 | 225 Million CNY | 125.0% |
| 2008 | 100 Million CNY | -48.72% |
| 2007 | 195 Million CNY | -14.1% |
| 2006 | 227 Million CNY | 1.34% |
| 2005 | 224 Million CNY | 1300.0% |
| 2004 | 16 Million CNY | -55.56% |
| 2003 | 36 Million CNY | 0.0% |
| 2002 | 36 Million CNY | -28.0% |
| 2001 | 50 Million CNY | 0.0% |
| 2000 | 50 Million CNY | 0.0% |
| 1999 | 50 Million CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 1.23 Billion CNY | -13.97% |
| 2024 Q3 | 244.36 Million CNY | -80.26% |
| 2024 Q1 | 1.43 Billion CNY | 1.84% |
| 2023 Q2 | 1.87 Billion CNY | -3.42% |
| 2023 Q3 | 1.78 Billion CNY | -4.97% |
| 2023 Q4 | 1.41 Billion CNY | -20.74% |
| 2023 FY | 1.41 Billion CNY | -2.64% |
| 2023 Q1 | 1.94 Billion CNY | 33.83% |
| 2022 Q1 | 929.25 Million CNY | -16.74% |
| 2022 FY | 1.45 Billion CNY | 30.04% |
| 2022 Q4 | 1.45 Billion CNY | 4.35% |
| 2022 Q3 | 1.39 Billion CNY | 65.72% |
| 2022 Q2 | 839.23 Million CNY | -9.69% |
| 2021 Q3 | 1.18 Billion CNY | -12.69% |
| 2021 Q1 | 780.73 Million CNY | -23.46% |
| 2021 FY | 1.11 Billion CNY | 9.41% |
| 2021 Q2 | 1.35 Billion CNY | 74.15% |
| 2021 Q4 | 1.11 Billion CNY | -5.98% |
| 2020 Q4 | 1.02 Billion CNY | 23.41% |
| 2020 FY | 1.02 Billion CNY | -68.44% |
| 2020 Q1 | 3.33 Billion CNY | 3.23% |
| 2020 Q2 | 2.11 Billion CNY | -36.57% |
| 2020 Q3 | 826.52 Million CNY | -60.94% |
| 2019 Q2 | 4.36 Billion CNY | -9.41% |
| 2019 Q4 | 3.23 Billion CNY | -26.2% |
| 2019 Q3 | 4.37 Billion CNY | 0.29% |
| 2019 Q1 | 4.82 Billion CNY | -6.51% |
| 2019 FY | 3.23 Billion CNY | -37.31% |
| 2018 Q1 | 2.61 Billion CNY | 192.89% |
| 2018 FY | 5.15 Billion CNY | 478.33% |
| 2018 Q4 | 5.15 Billion CNY | 36.14% |
| 2018 Q3 | 3.78 Billion CNY | -4.47% |
| 2018 Q2 | 3.96 Billion CNY | 51.83% |
| 2017 Q3 | 124.15 Million CNY | 148.31% |
| 2017 FY | 891.5 Million CNY | 123.15% |
| 2017 Q1 | 449.6 Million CNY | 12.54% |
| 2017 Q2 | 50 Million CNY | -88.88% |
| 2017 Q4 | 891.5 Million CNY | 618.07% |
| 2016 Q3 | 399.4 Million CNY | 0.03% |
| 2016 Q2 | 399.3 Million CNY | -50.0% |
| 2016 Q4 | 399.5 Million CNY | 0.03% |
| 2016 Q1 | 798.67 Million CNY | 0.03% |
| 2016 FY | 399.5 Million CNY | -49.96% |
| 2015 FY | 798.44 Million CNY | -1.7% |
| 2015 Q4 | 798.44 Million CNY | 0.03% |
| 2015 Q3 | 798.21 Million CNY | 0.03% |
| 2015 Q2 | 797.99 Million CNY | -1.78% |
| 2015 Q1 | 812.42 Million CNY | 0.02% |
| 2014 Q2 | 869.07 Million CNY | 0.03% |
| 2014 FY | 812.22 Million CNY | -6.49% |
| 2014 Q1 | 868.85 Million CNY | 0.03% |
| 2014 Q4 | 812.22 Million CNY | -6.57% |
| 2014 Q3 | 869.3 Million CNY | 0.03% |
| 2013 Q3 | 929.89 Million CNY | 2.35% |
| 2013 Q2 | 908.51 Million CNY | 77.85% |
| 2013 FY | 868.62 Million CNY | 73.48% |
| 2013 Q4 | 868.62 Million CNY | -6.59% |
| 2013 Q1 | 510.82 Million CNY | 2.02% |
| 2012 Q1 | 62.94 Million CNY | -0.1% |
| 2012 Q2 | 480.31 Million CNY | 663.09% |
| 2012 FY | 500.7 Million CNY | 694.65% |
| 2012 Q3 | 486.64 Million CNY | 1.32% |
| 2012 Q4 | 500.7 Million CNY | 2.89% |
| 2011 FY | 63 Million CNY | -72.0% |
| 2011 Q4 | 63 Million CNY | -72.0% |
| 2011 Q3 | 225 Million CNY | 0.0% |
| 2011 Q2 | 225 Million CNY | 0.0% |
| 2011 Q1 | 225 Million CNY | 0.0% |
| 2010 Q2 | 225 Million CNY | 0.0% |
| 2010 Q3 | 225 Million CNY | 0.0% |
| 2010 Q1 | 225 Million CNY | 0.0% |
| 2010 Q4 | 225 Million CNY | 0.0% |
| 2010 FY | 225 Million CNY | 0.0% |
| 2009 Q2 | 225 Million CNY | 125.0% |
| 2009 Q4 | 225 Million CNY | -26.23% |
| 2009 Q1 | 100 Million CNY | 0.0% |
| 2009 FY | 225 Million CNY | 125.0% |
| 2009 Q3 | 305 Million CNY | 35.56% |
| 2008 Q4 | 100 Million CNY | -33.33% |
| 2008 FY | 100 Million CNY | -48.72% |
| 2008 Q1 | 150 Million CNY | -23.08% |
| 2008 Q2 | 150 Million CNY | 0.0% |
| 2008 Q3 | 150 Million CNY | 0.0% |
| 2007 FY | 195 Million CNY | -14.1% |
| 2007 Q4 | 195 Million CNY | -34.34% |
| 2007 Q3 | 297 Million CNY | 36.87% |
| 2007 Q2 | 217 Million CNY | -4.41% |
| 2007 Q1 | 227 Million CNY | 0.0% |
| 2006 Q3 | 269 Million CNY | 0.0% |
| 2006 Q4 | 227 Million CNY | -15.61% |
| 2006 Q2 | 269 Million CNY | 20.09% |
| 2006 FY | 227 Million CNY | 1.34% |
| 2006 Q1 | 224 Million CNY | 0.0% |
| 2005 Q4 | 224 Million CNY | 124.0% |
| 2005 FY | 224 Million CNY | 1300.0% |
| 2005 Q1 | - CNY | -100.0% |
| 2005 Q2 | 80 Million CNY | 0.0% |
| 2005 Q3 | 100 Million CNY | 25.0% |
| 2004 Q1 | 36 Million CNY | 0.0% |
| 2004 Q4 | 16 Million CNY | 0.0% |
| 2004 Q3 | 16 Million CNY | 0.0% |
| 2004 Q2 | 16 Million CNY | -55.56% |
| 2004 FY | 16 Million CNY | -55.56% |
| 2003 Q1 | 36 Million CNY | 0.0% |
| 2003 Q2 | 36 Million CNY | 0.0% |
| 2003 FY | 36 Million CNY | 0.0% |
| 2003 Q3 | 36 Million CNY | 0.0% |
| 2003 Q4 | 36 Million CNY | 0.0% |
| 2002 FY | 36 Million CNY | -28.0% |
| 2002 Q2 | 86 Million CNY | 0.0% |
| 2002 Q4 | 36 Million CNY | 0.0% |
| 2002 Q3 | 36 Million CNY | -58.14% |
| 2001 FY | 50 Million CNY | 0.0% |
| 2000 FY | 50 Million CNY | 0.0% |
| 1999 FY | 50 Million CNY | 0.0% |